Cardiovascular Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic Kidney Disease in Octogenarian Population

Authors

David Song, Department of Internal Medicine, Icahn school of Medicine at Mount Sinai Elmhurst Hospital, Queens, New York.
Yasar Sattar, Department of Cardiovascular Medicine, West Virginia University, Morgantown, West Virginia.
Mohammed Faisaluddin, Rochester Regional HealthFollow
Usama Talib, Deparmtent of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky.
Neel Patel, Deparmtent of Internal Medicine, New York Medical College/Landmark Medical Center, Woonsocket, Rhode Island.
Izza Shahid, Deparmtent of Internal Medicine, Dow Medical College, Karachi, Pakistan.
Amro Taha, Deparmtent of Internal Medicine, Weiss Memorial Hospital, Chicago, Illinois.
Fnu Raheela, Deparmtent of Internal Medicine, University of Toledo, Toledo, Ohio.
Prasana Sengodon, Department of Cardiovascular Medicine, West Virginia University, Morgantown, West Virginia.
Maria Riasat, Deparmtent of Internal Medicine, Icahn School of Medicine at Mount Sinai Beth Israel, Manhattan, New York.
Vaibhav Shah, Department of Internal Medicine, Icahn school of Medicine at Mount Sinai Elmhurst Hospital, Queens, New York.
Karthik Gonuguntla, Department of Cardiovascular Medicine, West Virginia University, Morgantown, West Virginia.
Mahboob Alam, Department of Cardiovascular Medicine, Baylor College of Medicine, Houston, Texas.
Islam Elgendy, Deparmtent of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky.
Ramesh Daggubati, Department of Cardiovascular Medicine, West Virginia University, Morgantown, West Virginia.
M Chadi Alraies, Department of Cardiovascular Medicine, Detroit Medical Center, Detroit, Michigan.

Department

Internal Medicine

Document Type

Article

Publication Title

The American Journal of Cardiology

Abstract

Limited data are available regarding in-hospital outcomes of transcatheter aortic valve implantation (TAVI) in the octogenarian population with chronic kidney disease (CKD). We sought to study the cardiovascular outcomes of TAVI in CKD hospitalization with different stages at the national cohort registry. We used the National Inpatient Sample database to compare TAVI CKD low-grade (LG) (stage I to IIIa, b) versus TAVI CKD high-grade (HG) (stage IV to V) in octogenarians. Outcomes such as inpatient mortality, cardiogenic shock, new permanent pacemaker implantation, acute kidney injury), sudden cardiac arrest, mechanical circulatory support, major bleeding, transfusion, and resource utilization were compared between the 2 cohorts. A total of 74,766 octogenarian patients (TAVI CKD-HG n = 12,220; TAVI CKD-LG n = 62,545) were included in our study. On matched analysis, TAVI CKD-HG had higher odds of in-hospital mortality (adjusted odds ratio [aOR] 2.18, 95% confidence interval [CI] 1.0-2.5, p < 0.0001), cardiogenic shock (aOR 1.22, 95% CI 1.07 to 1.39, p = 0.0019), permanent pacemaker implantation (aOR 1.14, 95% CI 1.06 to 1.23, p = 0.0006), acute kidney injury (aOR 1.19, 95% CI 1.13 to 1.27, p < 0.0001), sudden cardiac arrest (aOR 1.32, 95% CI 1.09 to 1.61, p = 0.004), major bleeding (aOR 1.1, 95% CI 1.006 to 1.22, p < 0.0368) and higher rates of blood transfusion (aOR 1.62, 95% CI 1.5 to 1.75, p < 0.0001) when compared with the TAVI CKD-LG cohort. However, there was no statistically significant difference in the odds of cerebrovascular accident and mechanical circulatory support use between the 2 groups.

First Page

163

Last Page

171

DOI

10.1016/j.amjcard.2023.07.083

Volume

211

Publication Date

1-15-2024

Medical Subject Headings

Aged, 80 and over; Humans; Transcatheter Aortic Valve Replacement; Octogenarians; Aortic Valve Stenosis (complications, surgery); Shock, Cardiogenic (epidemiology); Treatment Outcome; Renal Insufficiency, Chronic (complications, epidemiology); Aortic Valve (surgery); Acute Kidney Injury (epidemiology); Death, Sudden, Cardiac; Hemorrhage; Risk Factors

PubMed ID

38043436

Share

COinS